ProCE Banner Events


An MCL Quiz Game: Experts Review New and Emerging Therapies to Optimize Clinical Outcomes

Register now for this interactive quiz game satellite symposium held in conjunction with the 65th American Society of Hematology (ASH) Annual Meeting in San Diego to hear about the recent advances in MCL for the optimization and individualization of patient care. After the meeting, view the on-demand webcast and download the associated slideset for use in your clinic.

Physicians: maximum of 2.00 AMA PRA Category 1 Credits™

This event has expired. No longer available for credits.

Who Should Attend

This program is intended for physicians and other healthcare professionals who care for patients with mantle cell lymphoma.

Time and location

Friday, December 08, 2023

11:30 AM - 1:30 PM Pacific Time (PT)


Marriott Marquis San Diego Marina
333 W Harbor Dr.
San Diego, California 92101

Pacific Ballroom 21-22

Ann LaCasce, MD, MMSc

Associate Professor of Medicine
Lymphoma Program
Dana-Farber Cancer Institute
Boston, Massachusetts

John P. Leonard, MD

Senior Associate Dean for Innovation and Initiatives
Chair (Interim), Weill Department of Medicine
Richard T. Silver Distinguished Professor of Hematology and Medical Oncology
Weill Cornell Medicine/NewYork-Presbyterian
New York, New York

Matthew Lunning, DO, FACP

Associate Professor
Fred & Pamela Buffett Cancer Center
University of Nebraska Medical Center
Omaha, Nebraska


Registration & Lunch: 11:00 AM - 11:30 AM PT

  • Quiz questions and case discussion 1: Recent Changes to the MCL Treatment Landscape
    • Current treatment algorithm
    • Role of BTKis
    • Unmet clinical needs
  • Quiz questions and case discussion 2: Current/Emerging Roles of BTKis in Untreated MCL
    • Mechanisms, PK/PD, and efficacy of currently available BTKis
    • BTKis in transplant-eligible patients
    • Improving on BR in first-line MCL without transplant
  • Quiz questions and case discussion 3: Selecting and Sequencing BTKis in R/R MCL
    • Development of resistance and intolerance to covalent BTKis
    • Treatment options and sequencing after BR plus BTKi
  • Panel discussions: Impact of New Data on Current Clinical Challenges
    • Combining and sequencing of novel agents
    • Overcoming barriers to and challenges with BTKi therapy
    • Key abstracts at SOHO 2023 and ASH 2023
  • Closing Remarks, Audience Question and Answer Session


Venue Name

Marriott Marquis San Diego Marina


Marriott Marquis San Diego Marina
333 W Harbor Dr.
San Diego, California 92101

Room Name

Pacific Ballroom 21-22


Goal Statement
The goal of this program is to improve the knowledge and competence of learners in effort to optimize treatment for patients with mantle cell lymphoma.

Target Audience
This program is intended for physicians and other healthcare professionals who care for patients with mantle cell lymphoma. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Select optimal first-line treatment for patients with MCL who are not candidates for aggressive therapy
  • Develop BTKi-based therapeutic strategies for patients with newly diagnosed MCL who are eligible for ASCT
  • Plan BTKi-based therapeutic strategies for patients with R/R MCL, taking into consideration guideline recommendations, new indications, and recent practice-changing clinical trial results
  • Manage treatment-related symptoms in patients with MCL receiving BTKi-based therapy to optimize adherence and clinical outcomes
  • Identify patients with MCL who may be eligible for ongoing clinical trials evaluating currently available and emerging BTKis and BTKi-based combinations


Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.


Provided by Clinical Care Options, LLC.

Supported by an educational grant from AstraZeneca.

Contact Information

For customer support please click here.

Mailing Address:

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Additional Information

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.